Poolbeg Pharma PLC (LSE: POLB) is a clinical-stage biopharma company focused on infectious disease and immunotherapy. With a capital-light model, Poolbeg in-licenses promising candidates and develops them to early clinical stages. Its portfolio includes influenza, oncology, and long-COVID assets, targeting high-impact unmet needs.
A fresh wave of meme stock frenzy has gripped markets this week, with retail traders reigniting the speculative fire around stocks like Opendoor, Kohl’s, and Krispy Kreme